Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082242011> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2082242011 endingPage "2351" @default.
- W2082242011 startingPage "2349" @default.
- W2082242011 abstract "Current treatment in multiple myeloma consists of three courses of chemotherapy in low doses with subsequent hematopoietic stem cell mobilization to the peripheral blood using high-dose cyclophosphamide, collection and conditioning with high-dose chemotherapy (melphalan) followed by retransplantation of autologous peripheral blood stem cells (PBSCT). Only a few studies compare the effects of different phases of therapy on parameters, such as monoclonal immunoglobulin level and the presence of malignant CD38(+) and CD56(+) cells in blood and marrow. The aim of this study was to compare the effects of these two major phases of treatment (conventional and high dose) in the same patients, and furthermore, to compare the effects of the second course of high-dose therapy followed by PBSCT with the effects of the first one. Fifteen patients were included in the study. On average, conventional chemotherapy only slightly reduced the values of all disease markers. In contrast, high-dose therapy resulted in a dramatic effect, rapidly normalizing the values of all parameters. The effects of second PBSCT were only modest compared to the first. These data suggest that high-dose therapy is an efficient method to reduce tumor load in multiple myeloma. Conventional-dose chemotherapy may be simply a waste of time for some patients and may be either omitted or administered after high-dose therapy to consolidate remission." @default.
- W2082242011 created "2016-06-24" @default.
- W2082242011 creator A5011778759 @default.
- W2082242011 creator A5031283927 @default.
- W2082242011 creator A5039031801 @default.
- W2082242011 creator A5055318902 @default.
- W2082242011 creator A5061299820 @default.
- W2082242011 creator A5068516443 @default.
- W2082242011 creator A5084110989 @default.
- W2082242011 date "2003-09-01" @default.
- W2082242011 modified "2023-09-27" @default.
- W2082242011 title "Evaluation of relative anti-myeloma activity of high-dose melphalan followed by the first peripheral blood stem cell transplantation, as compared with the second transplantation, and to VAD chemotherapy" @default.
- W2082242011 cites W1524905787 @default.
- W2082242011 cites W1971367127 @default.
- W2082242011 cites W20342555 @default.
- W2082242011 cites W2066777762 @default.
- W2082242011 cites W2116216500 @default.
- W2082242011 cites W2278055600 @default.
- W2082242011 cites W2397577365 @default.
- W2082242011 cites W181450122 @default.
- W2082242011 cites W2333363976 @default.
- W2082242011 doi "https://doi.org/10.1016/s0041-1345(03)00829-7" @default.
- W2082242011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14529938" @default.
- W2082242011 hasPublicationYear "2003" @default.
- W2082242011 type Work @default.
- W2082242011 sameAs 2082242011 @default.
- W2082242011 citedByCount "0" @default.
- W2082242011 crossrefType "journal-article" @default.
- W2082242011 hasAuthorship W2082242011A5011778759 @default.
- W2082242011 hasAuthorship W2082242011A5031283927 @default.
- W2082242011 hasAuthorship W2082242011A5039031801 @default.
- W2082242011 hasAuthorship W2082242011A5055318902 @default.
- W2082242011 hasAuthorship W2082242011A5061299820 @default.
- W2082242011 hasAuthorship W2082242011A5068516443 @default.
- W2082242011 hasAuthorship W2082242011A5084110989 @default.
- W2082242011 hasConcept C126322002 @default.
- W2082242011 hasConcept C126894567 @default.
- W2082242011 hasConcept C141071460 @default.
- W2082242011 hasConcept C143998085 @default.
- W2082242011 hasConcept C2776364478 @default.
- W2082242011 hasConcept C2776694085 @default.
- W2082242011 hasConcept C2776755627 @default.
- W2082242011 hasConcept C2777408962 @default.
- W2082242011 hasConcept C2778684742 @default.
- W2082242011 hasConcept C28328180 @default.
- W2082242011 hasConcept C2911091166 @default.
- W2082242011 hasConcept C54355233 @default.
- W2082242011 hasConcept C71924100 @default.
- W2082242011 hasConcept C86803240 @default.
- W2082242011 hasConceptScore W2082242011C126322002 @default.
- W2082242011 hasConceptScore W2082242011C126894567 @default.
- W2082242011 hasConceptScore W2082242011C141071460 @default.
- W2082242011 hasConceptScore W2082242011C143998085 @default.
- W2082242011 hasConceptScore W2082242011C2776364478 @default.
- W2082242011 hasConceptScore W2082242011C2776694085 @default.
- W2082242011 hasConceptScore W2082242011C2776755627 @default.
- W2082242011 hasConceptScore W2082242011C2777408962 @default.
- W2082242011 hasConceptScore W2082242011C2778684742 @default.
- W2082242011 hasConceptScore W2082242011C28328180 @default.
- W2082242011 hasConceptScore W2082242011C2911091166 @default.
- W2082242011 hasConceptScore W2082242011C54355233 @default.
- W2082242011 hasConceptScore W2082242011C71924100 @default.
- W2082242011 hasConceptScore W2082242011C86803240 @default.
- W2082242011 hasIssue "6" @default.
- W2082242011 hasLocation W20822420111 @default.
- W2082242011 hasLocation W20822420112 @default.
- W2082242011 hasOpenAccess W2082242011 @default.
- W2082242011 hasPrimaryLocation W20822420111 @default.
- W2082242011 hasRelatedWork W2007459874 @default.
- W2082242011 hasRelatedWork W2022119793 @default.
- W2082242011 hasRelatedWork W2058829580 @default.
- W2082242011 hasRelatedWork W2353124159 @default.
- W2082242011 hasRelatedWork W2414051711 @default.
- W2082242011 hasRelatedWork W2415589513 @default.
- W2082242011 hasRelatedWork W2421304553 @default.
- W2082242011 hasRelatedWork W2432246041 @default.
- W2082242011 hasRelatedWork W2435256000 @default.
- W2082242011 hasRelatedWork W2950846836 @default.
- W2082242011 hasVolume "35" @default.
- W2082242011 isParatext "false" @default.
- W2082242011 isRetracted "false" @default.
- W2082242011 magId "2082242011" @default.
- W2082242011 workType "article" @default.